August 24, 2023 Comments Off on Drug Patent Expirations for the Week of August 20, 2023 Posted in: Uncategorized
VYVANSE (lisdexamfetamine dimesylate) Takeda pharms usa Patent: 7,718,619 Expiration: Aug 24, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expir…
August 24, 2023 Comments Off on New patent expiration for Takeda Pharms drug VYVANSE Posted in: Uncategorized
Annual Drug Patent Expirations for VYVANSE Vyvanse is a drug marketed by Takeda Pharms Usa and is included in two NDAs. It is available from one supplier. There are eighteen…
The post New patent expiration for Takeda Pharms drug VYVANSE appeared first …
